Triple-receptor agonists or triagonists in development target GLP-1, GIP, and glucagon receptors
And the estimated net price of Wegovy is over $800, nearly four and a half times as much as it cost in Denmark
Conclusion: This multicenter cohort study showed that heart transplant recipients with diabetes mellitus treated with SGLT2i had a significant reduction in the risk of graft failure, need for dialysis, all-cause hospitalization, and mortality compared to those not treated with SGLT2i
Whether treatment should be ended depends, among other things, on tolerability, blood pressure, pulse, possible interactions, and the course of treatment so far, and should always be decided by a doctor
10.1046/j.1432-1327.2000.01595.x Eur